PSAT1 and small cell lung carcinoma: The elevated expression of PSRC1 may promote the development of SCLC by influencing the cell cycle process and immune cell infiltration, while the increased expression of PSAT1 may contribute to the development of SCLC by affecting the cell cycle process.